Characterization of two cell lines with distinct phenotypes and genotypes established from a patient with renal cell carcinoma.

Two human renal carcinoma cell lines have been established from the same patient. One cell line (CCF-RC1) was obtained from the primary tumor and the second (CCF-RC2) was established from cells of the renal vein effluent of the perfused tumorous kidney. Although they were established from the same patient, the cell lines differed in certain biological properties. They have been passaged up to 50 times in vitro for about two years. Each has an epithelial morphology and exhibits mutilayering. Cell cycle time of CCF-RC1 and CCF-RC2 was 34 and 36 h, respectively. They exhibited anchorage independent growth, and the plating efficiency of CCF-RC2 in soft agar was higher than that of CCF-RC1. Both lines induced tumors in nude mice at the site of s.c. injection closely resembling the original tumor in histological examination. Electron microscopic features of both tumors in nude mice were consistent with epithelial origin. Doubling time of CCF-RC1 and CCF-RC2 in nude mice was 11 and 12 days, respectively. CCF-RC1 and CCF-RC2 have hypotetraploid karyotype and modal numbers of 83 and 73, presenting two and three marker chromosomes, respectively. Immunocytology with commercial monoclonal antibodies against renal carcinoma (URO-3) and cytokeratin (Mac 6) showed positive reactions with both lines, suggesting that these cell lines derived from renal epithelium. A murine monoclonal antibody (2E11) was generated against CCF-RC2 by the hybridoma technique; 2E11 reacted with CCF-RC2, but not with CCF-RC1. These cell lines may provide a useful model for the study of tumor heterogeneity and its relationship to metastasis.

[1]  N. Bander Monoclonal antibodies in urologic oncology , 1987, Cancer.

[2]  D. Lewis,et al.  Characterization of a renal cell carcinoma cell line suitable as a target for immunological studies in vitro and in the nu/nu mouse. , 1985, The Journal of urology.

[3]  J. Richie,et al.  New human renal carcinoma cell line established from a patient with erythrocytosis. , 1983, Cancer research.

[4]  R. Warnke,et al.  Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  J. Goding Antibody production by hybridomas. , 1980, Journal of immunological methods.

[6]  T. Hada,et al.  Characterization of an established cell line from human renal carcinoma. , 1979, Cancer research.

[7]  K. Rajewsky,et al.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. , 1979, Journal of immunology.

[8]  F. Schroeder,et al.  Renal cell carcinoma: two new cell lines and a serially transplantable nude mouse tumor (NC 65). Preliminary report. , 1978, Investigative urology.

[9]  W. Nelson-Rees,et al.  HeLa cultures defined. , 1976, Science.

[10]  M. Essex,et al.  Membrane antigens of murine leukaemia cells , 1974, Nature.

[11]  W. F. Simpson,et al.  Diploid and heteroploid human cell lines surveyed for Y chromosome fluorescence. , 1973, Nature: New biology.

[12]  M. Tannenbaum Ultrastructural pathology of human renal cell tumors. , 1971, Pathology annual.

[13]  Richter Km,et al.  The cultivation of several genitourinary tract tumors. , 1957 .